{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "11786656",
  "DateCompleted": {
    "Year": "2002",
    "Month": "02",
    "Day": "26"
  },
  "DateRevised": {
    "Year": "2018",
    "Month": "11",
    "Day": "30"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0009-3157",
      "JournalIssue": {
        "Volume": "47",
        "Issue": "6",
        "PubDate": {
          "Year": "2001",
          "Month": "Dec"
        }
      },
      "Title": "Chemotherapy",
      "ISOAbbreviation": "Chemotherapy"
    },
    "ArticleTitle": "Resistance to vancomycin, LY333328, ciprofloxacin and trovafloxacin of community-acquired and nosocomial strains of Enterococcus faecalis isolated in Badajoz (Spain) with and without high-level resistance to streptomycin and gentamicin.",
    "Pagination": {
      "StartPage": "415",
      "EndPage": "420",
      "MedlinePgn": "415-20"
    },
    "Abstract": {
      "AbstractText": [
        "In vitro resistance of community-acquired and nosocomial strains of Enterococcus faecalis isolated in Badajoz (Spain) were determined by a microdilution method. The isolates were identified with conventional MicroScan Pos Combo 4 I dehydrated panels. No resistance to glycopeptides was found, but LY333328 was 2-4 times more active than vancomycin. In the nosocomial strains, high-level resistance to streptomycin (HLRS) was 54.7%, and high-level resistance to gentamicin (HLRG) was 38.1%. Resistance to ciprofloxacin and trovafloxacin was 45.3 and 38.9%, respectively. In the community-acquired isolates, HLRS, HLRG, resistance to ciprofloxacin and resistance to trovafloxacin were 44.2, 17.3, 15.4 and 13.5%, respectively. Trovafloxacin was 2-4 times more active than ciprofloxacin against both groups of strains. An association between high-level resistance to aminoglycosides and resistance to fluoroquinolones was noted. The resistance to aminoglycosides did not influence the activity of vancomycin and LY333328."
      ],
      "CopyrightInformation": "Copyright 2001 S. Karger AG, Basel"
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Microbiology, Faculty of Medicine, Extremadura University, Avenida de Elvas s/n, 06071 Badajoz, Spain."
          }
        ],
        "LastName": "S\u00e1nchez-Silos",
        "ForeName": "R M",
        "Initials": "RM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "P\u00e9rez-Giraldo",
        "ForeName": "C",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Blanco",
        "ForeName": "M T",
        "Initials": "MT"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Mor\u00e1n",
        "ForeName": "F J",
        "Initials": "FJ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Hurtado",
        "ForeName": "C",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "G\u00f3mez-Garc\u00eda",
        "ForeName": "A C",
        "Initials": "AC"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Switzerland",
    "MedlineTA": "Chemotherapy",
    "NlmUniqueID": "0144731",
    "ISSNLinking": "0009-3157"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Bacterial Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Infective Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Fluoroquinolones"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Gentamicins"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Glycopeptides"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Lipoglycopeptides"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Naphthyridines"
    },
    {
      "RegistryNumber": "5E8K9I0O4U",
      "NameOfSubstance": "Ciprofloxacin"
    },
    {
      "RegistryNumber": "6Q205EH1VU",
      "NameOfSubstance": "Vancomycin"
    },
    {
      "RegistryNumber": "9F388J00UK",
      "NameOfSubstance": "trovafloxacin"
    },
    {
      "RegistryNumber": "PUG62FRZ2E",
      "NameOfSubstance": "oritavancin"
    },
    {
      "RegistryNumber": "Y45QSO73OB",
      "NameOfSubstance": "Streptomycin"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Anti-Bacterial Agents"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Anti-Infective Agents"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Ciprofloxacin"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Community-Acquired Infections"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cross Infection"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Resistance, Bacterial"
    },
    {
      "QualifierName": [
        "drug effects",
        "pathogenicity"
      ],
      "DescriptorName": "Enterococcus faecalis"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Fluoroquinolones"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Gentamicins"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Glycopeptides"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Gram-Positive Bacterial Infections"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Incidence"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Lipoglycopeptides"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Microbial Sensitivity Tests"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Naphthyridines"
    },
    {
      "QualifierName": [
        "epidemiology"
      ],
      "DescriptorName": "Spain"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Streptomycin"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Vancomycin"
    }
  ]
}